HomeCompareFRTX vs PEP

FRTX vs PEP: Dividend Comparison 2026

FRTX yields 213.90% · PEP yields 3.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FRTX wins by $176.94M in total portfolio value
10 years
FRTX
FRTX
● Live price
213.90%
Share price
$0.94
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$177.09M
Annual income
$92,250,740.75
Full FRTX calculator →
PEP
PepsiCo Inc.
● Live price
3.66%
Share price
$155.29
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$144.7K
Annual income
$63,430.49
Full PEP calculator →

Portfolio growth — FRTX vs PEP

📍 FRTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFRTXPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FRTX + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FRTX pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FRTX
Annual income on $10K today (after 15% tax)
$18,181.82/yr
After 10yr DRIP, annual income (after tax)
$78,413,129.64/yr
PEP
Annual income on $10K today (after 15% tax)
$311.45/yr
After 10yr DRIP, annual income (after tax)
$53,915.92/yr
At 15% tax rate, FRTX beats the other by $78,359,213.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FRTX + PEP for your $10,000?

FRTX: 50%PEP: 50%
100% PEP50/50100% FRTX
Portfolio after 10yr
$88.62M
Annual income
$46,157,085.62/yr
Blended yield
52.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

FRTX
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
-18.7
Piotroski
4/9
PEP
Analyst Ratings
1
Strong
15
Buy
28
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+11.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FRTX buys
0
PEP buys
0
No recent congressional trades found for FRTX or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFRTXPEP
Forward yield213.90%3.66%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$177.09M$144.7K
Annual income after 10y$92,250,740.75$63,430.49
Total dividends collected$167.49M$125.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: FRTX vs PEP ($10,000, DRIP)

YearFRTX PortfolioFRTX Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$32,090$21,390.37$10,854$514.44+$21.2KFRTX
2$98,489$64,151.88$11,982$758.21+$86.5KFRTX
3$289,391$184,008.00$13,526$1,136.44+$275.9KFRTX
4$814,951$505,302.85$15,727$1,741.93+$799.2KFRTX
5$2,201,885$1,329,887.07$19,012$2,750.28+$2.18MFRTX
6$5,714,120$3,358,103.33$24,173$4,514.44+$5.69MFRTX
7$14,258,620$8,144,511.98$32,789$7,793.80+$14.23MFRTX
8$34,250,418$18,993,694.31$48,258$14,354.51+$34.20MFRTX
9$79,287,637$42,639,690.06$78,586$28,686.63+$79.21MFRTX
10$177,088,513$92,250,740.75$144,688$63,430.49+$176.94MFRTX

FRTX vs PEP: Complete Analysis 2026

FRTXStock

Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was formerly known as Brickell Biotech, Inc. and changed its name to Fresh Tracks Therapeutics, Inc. in September 2022. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.

Full FRTX Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this FRTX vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FRTX vs SCHDFRTX vs JEPIFRTX vs OFRTX vs KOFRTX vs MAINFRTX vs MOFRTX vs PMFRTX vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.